Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Alvaro Gonzalez-Rajal

3PUBLICATIONS
42CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

Sort by Publication Date:
|May 13, 2021
A non-genetic, cell cycle-dependent mechanism of platinum resistance in lung adenocarcinoma.

Alvaro Gonzalez Rajal, Kamila A Marzec, Rachael A McCloy

|Jun 06, 2020
MTOR signaling orchestrates stress-induced mutagenesis, facilitating adaptive evolution in cancer.

Arcadi Cipponi, David L Goode, Justin Bedo

|Jul 27, 2018
Inhibition of activin signaling in lung adenocarcinoma increases the therapeutic index of platinum chemotherapy.

Kieren D Marini, David R Croucher, Rachael A McCloy

Pageof 1

Frequent Collaborators

3 joint publications

David R Croucher

2 joint publications

D Neil Watkins

2 joint publications

Andrew Burgess

2 joint publications

Jason E Cain

2 joint publications

Jordan F Hastings

2 joint publications

Max Nobis

1 joint publications

David L Goode

1 joint publications

Justin Bedo

1 joint publications

Marina Pajic

1 joint publications

Darren N Saunders

Frequent Collaborators

3 joint publications

David R Croucher

2 joint publications

D Neil Watkins

2 joint publications

Andrew Burgess

2 joint publications

Jason E Cain

Top Related Videos

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells <em>In Vitro</em> with a 2-step Dose-escalation Procedure
09:38

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells <em>In Vitro</em> with a 2-step Dose-escalation Procedure

Published on : Aug 11, 2017

9.0K
Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on : Jun 06, 2025

543
Network Pharmacology Prediction and Experimental Validation of <em>Trichosanthes</em>-<em>Fritillaria thunbergii</em> Action Mechanism Against Lung Adenocarcinoma
13:18

Network Pharmacology Prediction and Experimental Validation of <em>Trichosanthes</em>-<em>Fritillaria thunbergii</em> Action Mechanism Against Lung Adenocarcinoma

Published on : Mar 03, 2023

1.8K
See more related videos

Top Related Videos

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells <em>In Vitro</em> with a 2-step Dose-escalation Procedure
09:38

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells <em>In Vitro</em> with a 2-step Dose-escalation Procedure

Published on : Aug 11, 2017

9.0K
Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on : Jun 06, 2025

543
Network Pharmacology Prediction and Experimental Validation of <em>Trichosanthes</em>-<em>Fritillaria thunbergii</em> Action Mechanism Against Lung Adenocarcinoma
13:18

Network Pharmacology Prediction and Experimental Validation of <em>Trichosanthes</em>-<em>Fritillaria thunbergii</em> Action Mechanism Against Lung Adenocarcinoma

Published on : Mar 03, 2023

1.8K
See more related videos